[SRNE] QoQ Quarter Result on 31-Mar-2020 [#Q1]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
11-May-2020
Financial Year
2020
Quarter
31-Mar-2020 [#Q1]
Profit Trend
QoQ- -3.78%
YoY- 39.67%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Revenue 11,505 11,753 9,007 7,721 13,034 5,778 6,477 46.41%
PBT -73,068 -86,398 -82,213 -68,900 -69,110 -74,002 -70,654 2.25%
Tax 36 145 -1,919 -276 309 -221 -383 -
NP -71,502 -84,023 -77,740 -65,195 -62,820 -64,415 -56,762 16.55%
Tax Rate - - - - - - - -
Total Cost 83,007 95,776 86,747 72,916 75,854 70,193 63,239 19.78%
Ratio Analysis
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
NP Margin -621.49 -714.91 -863.11 -844.39 -481.97 -1,114.83 -876.36 -20.39%
Per Share
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
EPS -0.28 -0.33 -0.36 -0.36 -0.34 -0.49 -0.46 -28.06%
EPS Diluted -0.28 -0.33 -0.36 -0.36 -0.34 -0.46 -0.43 -24.77%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.